SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is experiencing a period of extreme volatility and intense retail attention following a recent rally, with the community actively debating whether the move is driven by genuine industrial demand for AI data-center power solutions or if it represents another cycle of speculative pump-and-dump behavior. Investors are closely monitoring management's ability to convert pipeline opportunities into commercial orders, while short sellers and long-term shareholders remain locked in a heated standoff over the stock's valuation and the risk of further dilution.

Penguin Solutions, Inc. engages in designing, building, and managing enterprise solutions. It operates through the following segments: Advanced Computing, Integrated Memory, and Optimized LED. The Advanced Computing segment offers platform solutions and services for artificial intelligence, high-performance computing, machine learning, advanced modeling, and the internet of things. The Integrated Memory refers to integrated memory solutions through the design and development. The Optimized LED segment comprises a broad portfolio of application-optimized LEDs. The company was founded in 1988 and is headquartered in Fremont, CA.

Penguin Solutions Inc.

Penguin Solutions is surging as investors react to a significant earnings beat and raised guidance, highlighting the company's growing role as a critical partner in the AI infrastructure and memory stack. Community sentiment is high, with active discussions focused on its strategic positioning within the NVIDIA ecosystem and the potential for a sustained multi-year growth cycle.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as momentum builds around its GLP-1/GIP obesity pipeline, with community members actively discussing a potential buyout or major partnership as institutional accumulation appears to intensify. Investors are eagerly front-running key upcoming clinical data readouts, fueling speculation about the stock's ability to challenge its 52-week highs and capture significant market share.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

Biocryst Pharmaceuticals is seeing intense community speculation and active trading volume driven by persistent buyout rumors and strategic shifts, including the closure of its internal discovery center to focus on capital-efficient partnerships. Traders are closely monitoring short interest and recent technical momentum, as investors weigh potential M&A scenarios against the company's long-term commercial execution.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

COMPASS Pathways is gaining significant momentum as investors anticipate the final Phase 3 durability data for its COMP360 treatment, which is critical for an upcoming FDA NDA submission. The community is actively debating the stock's potential for a major re-rating, fueled by recent board appointments, executive-level optimism about commercialization, and the broader institutional rotation into biotech stocks with significant clinical catalysts.

Rivian Automotive, Inc. engages in the design, development, and manufacture of category-defining electric vehicles and accessories. It operates through following segments: Automotive, Software and Services. The company was founded by Robert J. Scaringe in June 2009 and is headquartered in Irvine, CA.

Rivian Automotive Inc - Ordinary Shares - Class A

Rivian Automotive Inc

Rivian is facing intense volatility after announcing a 75-million share offering, which has sparked a heated debate between bulls who see the capital as essential for scaling production and securing government loans, and bears who are frustrated by the immediate dilution. While some investors are viewing the dip as a strategic buying opportunity following upward-revised revenue guidance, others are expressing significant frustration over the management's decision to dilute shares shortly after the stock reclaimed key technical levels.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is facing heightened scrutiny after Wolfspeed filed a patent infringement lawsuit targeting core GaN and SiC product lines, fueling community concerns about a potential long-term legal overhang. Investors are actively debating whether this litigation risk and recent volatility represent a buying opportunity for long-term AI infrastructure exposure or if the stock remains overvalued and vulnerable to further downside.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is gaining strong market momentum as it secures federal compliance under the Build America, Buy America Act, enabling its Rev8 lidar sensors to be deployed across critical U.S. infrastructure projects. Community discussions are highly bullish, with many investors focusing on the company's deepening integration into the physical AI and robotics supply chain through strategic partnerships, viewing recent volatility as a healthy consolidation before a potential move toward higher valuation targets.

Vera Therapeutics, Inc. is a clinical stage biotechnical company which engages in the development and commercialization of transformative treatments for immunological diseases. The company was founded by Marshall Fordyce in May 2016 and is headquartered in Brisbane, CA.

Vera Therapeutics Inc - Ordinary Shares - Class A

Vera Therapeutics is currently in the spotlight as investors weigh the potential of its IgA nephropathy treatment against emerging clinical competition, while keeping a close watch for the upcoming pivotal trial readout. The community is actively discussing the stock's M&A prospects, the impact of recent clinical data, and whether the current valuation fully reflects the commercial path for its lead candidate, atacicept.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

TeraWulf is currently the focus of heavy market discussion after announcing a 20-year, 19 billion dollar lease agreement with AI leader Anthropic for its Kentucky data center campus. While the community is debating whether the stock's muted price reaction is due to market-wide volatility, short-selling pressure, or a 'sell-the-news' response, many investors remain bullish on the long-term potential of this transition from bitcoin mining to AI infrastructure.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? Did iRhythm Technologies, Inc. Insiders Breach their Fiduciary Duties to Shareholders? PR Newswire NEW YORK, July 3, 2026 Shareholders are encouraged to contact the firm to discuss their rights and options at no...

Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm

Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm Kuehn Law Encourages Investors of iRhythm Technologies, Inc. to Contact Law Firm PR Newswire NEW YORK, July 2, 2026 NEW YORK, July 2, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is...

16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap

16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap 16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap PR Newswire TORONTO, ON, June 16, 2026 Issued on behalf of Ventripoint Diagnostics Ltd.As the number of...

iRhythm Technologies Touts Medicare Win, Zio Growth and AI-Driven Margin Gains

iRhythm Technologies Touts Medicare Win, Zio Growth and AI-Driven Margin Gains...

Wall Street Analysts Predict a 57.21% Upside in IRHYTHM HLDGS (IRTC): Here's  What You Should Know

The consensus price target hints at a 57.2% upside potential for IRHYTHM HLDGS (IRTC). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Why iRhythm Holdings, Inc. (IRTC) is a Top Momentum Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Comerica Bank Sells 13,381 Shares of iRhythm Technologies $IRTC

Comerica Bank cut its stake in shares of iRhythm Technologies (NASDAQ:IRTC - Free Report) by 47.1% in the 4th quarter, according to the company in its most recent disclosure with the Securities and...

Citigroup Issues Positive Forecast for iRhythm Technologies (NASDAQ:IRTC) Stock Price

Citigroup increased their price objective on shares of iRhythm Technologies from $155.00 to $157.00 and gave the company a "buy" rating in a report on Monday...

IRTC Stock Up on Q1 Earnings & Revenue Beat, FY26 Outlook Raised

iRhythm narrows Q1 losses, lifts 2026 outlook and posts 25.7% revenue growth as strong demand and margin gains drive momentum.

iRhythm Technologies (NASDAQ:IRTC) Receives Consensus Rating of "Moderate Buy" from Brokerages

Shares of iRhythm Technologies (NASDAQ:IRTC - Get Free Report) have earned a consensus rating of "Moderate Buy" from the fifteen ratings firms that are covering the stock, Marketbeat.com reports. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating...

iRhythm Holdings, Inc. is a digital healthcare company, which engages in the provision of design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.

iRhythm Holdings Inc.

Wells Fargo Upgrades iRhythm Technologies Stock, Raises Price Target To $130: Retail’s Thrilled

Equity

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

IRTCiRhythm Technologies Inc

Latest IRTC News